Hyper-igd Syndrome
📧 Sign up to get email alerts when something new happens for Hyper-igd Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2018-06-18Clinical Trial Update: B7 Coreceptor Molecules in Hyper IgD Syndrome Form of Mevalonate Kinase Deficiency
The trial NCT01568736 investigating B7 coreceptor molecules in Hyper IgD Syndrome form of Mevalonate Kinase Deficiency has been withdrawn.